Imidazole → HCID 178481629、化合物

HRID 1507054

反応式

HRID 1507054 の反応式
[CH3:1][N:2]1[C:6](=[O:7])[C:5](=O)[NH:4][C:3]1=[O:9].N1C=CN=C1.C(N(CC)CC)C.Cl[Si](C)(C)C.[CH2:27]([NH2:34])[C:28]1[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=1>C(Cl)(Cl)Cl.O>[CH2:27]([NH:34][C:5]1[C:6](=[O:7])[N:2]([CH3:1])[C:3](=[O:9])[N:4]=1)[C:28]1[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=1

参加物

8

実験手順

To a solution of 1-methyl-imidazolidine-2,4,5-trione (Example 1.3, Part A) (800 mg, 6.25 mmol), imidazole (467 mg, 6.87 mmol), N,N-dimethylaminopyridine (cat.) and triethylamine (1.82 mL, 13.1 mmol) in chloroform (13 mL) was added chlorotrimethylsilane (1.67 mL, 13.1 mmol) dropwise at room temperature under a nitrogen atmosphere, and the reaction mixture was stirred for 2 h. Benzylamine (0.75 mL, 6.87 mmol) was added and the reaction mixture was stirred for a further 22.5 h. The reaction mixture was diluted with chloroform and water and the chloroform extracts were dried and evaporated. The crude product was purified by column chromatography (PS with gradient elution to DCM:EtOAc 3:1) to give the product as a colourless solid (838 mg, 62%), mp 152-154° C. δH (300 MHz, CD3CN) 7.95 (v br s, 1H, NH), 7.41-7.27 (m, 5H, PhH), 4.64 (s, 2H, CH2), 2.95 (s, 3M, CH3). Mass spectrum (ESI) m/z 218 (M+H).

後処理

  1. stirringthe reaction mixture was stirred for a further 22.5 h
  2. dry with materialthe chloroform extracts were dried
  3. customevaporated
  4. customThe crude product was purified by column chromatography (PS with gradient elution to DCM:EtOAc 3:1)

出典と根拠

ORDレコード
ord-82fa9de6dd494da5901287e5a16c3745
出典データセット
uspto-grants-2015_12
特許番号
US09221799B2

関連ノート

読み込み中…